These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30280246)

  • 21. Comparison of diffusion-weighted MRI with 18F-fluorodeoxyglucose-positron emission tomography/CT and electroencephalography in sporadic Creutzfeldt-Jakob disease.
    Xing XW; Zhang JT; Zhu F; Ma L; Yin DY; Jia WQ; Huang XS; Pu CQ; Lang SY; Yu SY
    J Clin Neurosci; 2012 Oct; 19(10):1354-7. PubMed ID: 22795494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
    Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
    Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent diffusion coefficient value of gastric cancer by diffusion-weighted imaging: correlations with the histological differentiation and Lauren classification.
    Liu S; Guan W; Wang H; Pan L; Zhou Z; Yu H; Liu T; Yang X; He J; Zhou Z
    Eur J Radiol; 2014 Dec; 83(12):2122-2128. PubMed ID: 25442484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective comparison between magnetic resonance imaging and computed tomography in colorectal cancer staging.
    Koh FHX; Tan KK; Teo LLS; Ang BWL; Thian YL
    ANZ J Surg; 2018 Jun; 88(6):E498-E502. PubMed ID: 28803449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT.
    Satoh Y; Ichikawa T; Motosugi U; Kimura K; Sou H; Sano K; Araki T
    AJR Am J Roentgenol; 2011 Feb; 196(2):447-53. PubMed ID: 21257899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy response evaluation in a mouse model of gastric cancer using intravoxel incoherent motion diffusion-weighted MRI and histopathology.
    Cheng J; Wang Y; Zhang CF; Wang H; Wu WZ; Pan F; Hong N; Deng J
    World J Gastroenterol; 2017 Mar; 23(11):1990-2001. PubMed ID: 28373765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.
    Nketiah G; Elschot M; Kim E; Teruel JR; Scheenen TW; Bathen TF; Selnæs KM
    Eur Radiol; 2017 Jul; 27(7):3050-3059. PubMed ID: 27975146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-volume apparent diffusion coefficient-based entropy parameters for assessment of gastric cancer aggressiveness.
    Liu S; Zheng H; Zhang Y; Chen L; Guan W; Guan Y; Ge Y; He J; Zhou Z
    J Magn Reson Imaging; 2018 Jan; 47(1):168-175. PubMed ID: 28471511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of solid-type serous cystic neoplasm from neuroendocrine tumour in the pancreas: value of abdominal MRI with diffusion-weighted imaging in comparison with MDCT.
    Jang KM; Kim SH; Song KD; Kim YK; Lee SJ; Choi D
    Clin Radiol; 2015 Feb; 70(2):153-60. PubMed ID: 25465293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DW-MRI of the urogenital tract: applications in oncology.
    Petralia G; Thoeny HC
    Cancer Imaging; 2010 Oct; 10 Spec no A(1A):S112-23. PubMed ID: 20880781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer.
    Afaq A; Koh DM; Padhani A; van As N; Sohaib SA
    BJU Int; 2011 Dec; 108(11):1716-22. PubMed ID: 21631696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography.
    Giganti F; Orsenigo E; Arcidiacono PG; Nicoletti R; Albarello L; Ambrosi A; Salerno A; Esposito A; Petrone MC; Chiari D; Staudacher C; Del Maschio A; De Cobelli F
    Gastric Cancer; 2016 Jan; 19(1):216-25. PubMed ID: 25614468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.
    Gaeta M; Benedetto C; Minutoli F; D'Angelo T; Amato E; Mazziotti S; Racchiusa S; Mormina E; Blandino A; Pergolizzi S
    Acad Radiol; 2014 Oct; 21(10):1286-93. PubMed ID: 25088834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronal diffusion-weighted magnetic resonance imaging of the kidney: agreement with axial diffusion-weighted magnetic imaging in terms of apparent diffusion coefficient values.
    Wang HY; Wang J; Tang YH; Ye HY; Ma L
    Chin Med J (Engl); 2015 Feb; 128(4):499-503. PubMed ID: 25673453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
    Dalah E; Moraru I; Paulson E; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance diffusion-weighted imaging: extraneurological applications.
    Colagrande S; Carbone SF; Carusi LM; Cova M; Villari N
    Radiol Med; 2006 Apr; 111(3):392-419. PubMed ID: 16683086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion MRI in early cancer therapeutic response assessment.
    Galbán CJ; Hoff BA; Chenevert TL; Ross BD
    NMR Biomed; 2017 Mar; 30(3):. PubMed ID: 26773848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.